Warning: mail() has been disabled for security reasons in /home/markrref/public_html/usmarketbuzz.com/wp-content/mu-plugins/bps-mu-tools.php on line 110

Warning: Cannot modify header information - headers already sent by (output started at /home/markrref/public_html/usmarketbuzz.com/wp-content/mu-plugins/bps-mu-tools.php:110) in /home/markrref/public_html/usmarketbuzz.com/wp-content/plugins/bigcontact/BigContact.php on line 43

Warning: Cannot modify header information - headers already sent by (output started at /home/markrref/public_html/usmarketbuzz.com/wp-content/mu-plugins/bps-mu-tools.php:110) in /home/markrref/public_html/usmarketbuzz.com/wp-includes/feed-rss2.php on line 8
PDC Energy Inc(NASDAQ:PDCE) – US Market Buzz http://www.usmarketbuzz.com Nation and Economy Mon, 20 Jul 2020 16:28:22 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.23 Traders Buzz: Radius Health Inc(NASDAQ:RDUS), PDC Energy Inc(NASDAQ:PDCE), Jones Energy Inc(NYSE:JONE) http://www.usmarketbuzz.com/traders-buzz-radius-health-incnasdaqrdus-pdc-energy-incnasdaqpdce-jones-energy-incnysejone-2532 Thu, 18 Dec 2014 15:32:55 +0000 http://www.usmarketbuzz.com/?p=2532 Lakeway, NY — (MARKET NEWS CALL) — 12/18/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Radius Health Inc(NASDAQ:RDUS), PDC Energy Inc(NASDAQ:PDCE), Jones Energy Inc(NYSE:JONE).

Radius Health Inc(NASDAQ:RDUS)’s shares gained 17.76% to $30.97 in the last trading session. The company on Dec. 11 announced today that it presented data from a Phase 1 clinical study on estrogen receptor engagement by the investigational drug RAD1901, a tissue-selective estrogen receptor degrader (SERD), in a poster presentation at the 2014 San Antonio Breast Cancer Symposium (SABCS).

Should Investors Buy RDUS After The Recent Development? Find Out Here

Despite advances in the treatment of metastatic breast cancer through modulation of estrogen receptor (ER) activity, after initial efficacy, the use of hormonal therapies is frequently followed by the development of de novo or acquired endocrine resistance.

PDC Energy Inc(NASDAQ:PDCE)’s stock climbed 17.51% to $40. The company on Dec. 8 announced its capital budget and production guidance for 2015. PDC’s capital budget for 2015 is approximately $557 million, a decrease of 14% compared to its 2014 capital budget. The Company’s 2015 budget includes $526 million of development capital and $31 million for lease maintenance, exploration and other expenditures. The 2015 capital budget is focused on organic growth opportunities in PDC’s Inner and Middle core areas of the Wattenberg Field.

Is PDCE Going To Rise or Fall After Today’s Price Action? Find Out Here

Jones Energy Inc(NYSE:JONE)’s stock climbed 17.51% to $12.35. The company on Dec. 10 announced that it recently acquired a contiguous block of 5,120 net acres in Hutchinson County, Texas, prospective for its primary drilling target, the Cleveland sandstone. The lease was acquired on favorable commercial terms similar to recent lease activity by Jones Energy. The lease terms provide Jones Energy with 100% working interest at all depths. The initial block represents 40 net drilling locations in the Cleveland formation, which equates to half a year of drilling inventory at current activity levels.

Can Traders Buy JONE After The Solid Rally? Get Free Trend Analysis Here

About thenextbigtrade.com

thenextbigtrade.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. thenextbigtrade.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed “informational edge” which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.

Disclaimer

The assembled information disseminated by thenextbigtrade.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. thenextbigtrade.com does expect that investors will buy and sell securities based on information assembled and presented in thenextbigtrade.com. PLEASE always do your own due diligence, and consult your financial advisor.

 

]]>